A Gastro Compass project GastroLens first version live

Meet GastroLens, the live first-version assessment tool from GastroCompass.

Gastro Compass is the umbrella project behind GastroLens. GastroLens is now live in its first version as the interactive research-mode tool built to help document persistent symptom patterns related to early-onset colorectal cancer concern. It remains non-diagnostic, safety-first, and not clinically validated, but it is now available to launch directly from the GastroCompass site as the connected product experience.

  • Built on completed research, design work, and a public project platform
  • Launch from the site into the live GastroLens app flow: demos, intake, results, and Judge Mode
  • Safety-first: non-diagnostic, not clinically validated, and intentionally framed as a first-version research tool
GastroLens App Version 1 live
Live app surface

Start with a sample scenario

Minimal demo Persistent bleeding High-cluster demo

These presets mirror the live GastroLens demo and judging flow.

What lives here

What GastroLens is built around

Structured intake Explainable scoring Research-mode results

A step-based intake leads to an explainable research summary.

Safety framing

Research mode, not diagnosis

Informational only Non-diagnostic Clinician follow-up encouraged

Safety language stays non-diagnostic and follow-up oriented.

Step 1 of 4

Core symptoms

Rectal bleeding Persistent
Bowel change Significant
Duration 6+ weeks

Built as a short guided intake rather than a long medical questionnaire.

4-step flow

Move from symptoms to summary

1
Core symptoms Current step
2
Additional signals Next up
3
Risk context Family history and screening
4
Review and generate Prepare summary

The structure is visual, quick to complete, and easy to explain in a demo.

Navigation

Guided from start to result

Sample scenarios Guided prompts Generate summary

The live app keeps the research framing while making the workflow directly launchable from the site.

Research summary

Moderate flag

Total score 8
Pattern lens: persistent bleeding Driver summary: duration + bowel change Follow-up-oriented language

Based on the real GastroLens results panel.

Section contributions
Core symptoms 4 points
Additional pattern 2 points
Risk context 2 points

Scores are broken into explainable sections.

Safety-first output

Built for escalation support

Pattern explanation Safety note Care conversation

The result is framed as a reason to follow up, not a diagnosis.

Judge / Research Mode

What Judge Mode reveals

Interaction bonuses

Shows weighted rule interactions behind the score.

Validation notes

Flags contradictions and edge cases in the logic.

Share view

Presentation actions

Copy summary Print summary Start a new assessment

Designed for demos, judging, and review sessions.

Actual app direction

Deterministic, explainable, and demo-ready

Step-based intake Transparent scoring Judge mode extras

This panel reflects the actual GastroLens app structure now available from the site.

GastroLens app

Launch the interactive research-mode app

GastroLens is the live first-version interactive tool from Gastro Compass. It is designed to help organize persistent symptom patterns, apply symptom-first risk flagging logic, and prepare clearer non-diagnostic follow-up summaries for under-50 colorectal cancer concern.

Live on the site Not clinically validated Research-mode only
Interactive tool

Open GastroLens from GastroCompass

Use the main site for the research story and product context. Use GastroLens for the actual intake, scoring, and research-style results experience.

The problem

Digestive symptoms are easy to ignore. That is the problem.

Early-onset colorectal cancer can be missed because initial symptoms may look vague, intermittent, or easy to explain away. Changes in bowel habits, rectal bleeding, abdominal pain, fatigue, and other symptoms do not always trigger the right level of concern early enough. Gastro Compass is focused on that failure mode, and GastroLens now turns that work into a clearer, symptom-first first-version workflow for earlier escalation support.

What GastroLens now does

A live first-version workflow for symptom patterns that should not be ignored

Symptom Tracking

GastroLens lets users log rectal bleeding, bowel changes, abdominal pain, fatigue, weight loss, and symptom duration in a short structured intake.

Risk Context Intake

Family history, age group, and prior evaluation status help frame the symptom pattern more realistically.

Dual-View Summaries

Turn messy symptom history into one organized research-style summary that patients and clinicians can review more clearly.

Early Insight

Highlight symptom patterns that may warrant earlier physician follow-up instead of continued dismissal or delay.

Why the approach is different

Designed around a documented failure mode, with research first

Symptoms that are present, but ignored

Early-onset colorectal cancer is one of the few GI problems where warning symptoms often exist but are written off as IBS, hemorrhoids, stress, or anxiety.

Built from completed research

Gastro Compass brings together the completed paper, prototype design process, NHANES-grounded feasibility work, and three empirical analyses behind the concept.

Imaging is a roadmap feature

The imaging layer remains future work until it can be trained and validated on clinically meaningful data. The symptom-side is the tractable first build.

Safety-first framing

GastroLens is positioned as an escalation support tool, not a diagnosis tool. The product stays non-clinical until it is properly validated.

GastroLens workflow

Explore the 4-step flow, then launch the app

GastroLens is the live first-version interactive tool built from the Gastro Compass research hub. This section shows the current workflow, why it matters, and how the app is intended to support follow-up inside a research-mode interactive tool.

1

Capture

Users log symptoms such as rectal bleeding, bowel changes, abdominal pain, fatigue, and weight loss in a structured first-pass intake.

2

Organize

The app turns symptom entries into a clearer organized view instead of leaving important details scattered across memory and notes.

3

Analyze

The rule-based system weighs persistence, recurrence, and risk context like age group, family history, and prior evaluation status.

4

Escalate

The output is a summary that says the pattern warrants a conversation with a physician, not a diagnosis inside the app.

Research foundation

Research first, product second

Gastro Compass holds the research story together: the completed paper, prototype design work, NHANES-grounded feasibility analysis, and three empirical analyses that make the GastroLens concept more credible. The prototype comes after that foundation, not before it.

The goal is earlier recognition and better escalation, not diagnosis inside the product.

Evidence base

Completed research and feasibility work are what make GastroLens worth launching in a first version now.

Current product status

GastroLens is now live in a first version: research-driven, safety-first, and clearly framed as a non-diagnostic tool.

Why the rollout is staged

Why Gastro Compass leads with research before GastroLens

Gastro Compass is the umbrella project shaping the research and product direction. GastroLens is now the interactive first-version tool in that ecosystem, while the site continues to carry the deeper research story, safety framing, and broader project context around it.

Live first version now, broader rollout later.

What Gastro Compass provides

Research foundation, project story, public credibility, and the product hub around GastroLens.

Now live

GastroLens launch access, product updates, and continued research-mode improvements.

Current product direction

What the live first version of GastroLens is built around

Fast symptom capture

The live workflow uses quick structured logging rather than long medical forms.

Clear persistence views

The app centers on patterns that make ongoing changes easier to see and explain.

Risk-aware intake

Age group, family history, and prior evaluation stay part of the current review logic.

Export-ready summaries

The live tool is aimed at concise outputs users could bring into follow-up conversations.

Safety-first framing

The app stays intentionally non-diagnostic and clearly separate from clinical validation.

Research-mode design

The interface is live as a serious first version, with room to mature rather than pretending to be fully finished.

Credibility

Why this first-version tool is evidence-based

Gastro Compass is already carrying the research story: the completed paper, the product design process, NHANES-grounded feasibility work, three empirical analyses, and a safety-first non-clinical framing. That is what gives GastroLens a stronger foundation as a live first-version tool rather than a rushed public app.

Completed paper NHANES-grounded feasibility work Three empirical analyses Safety-first framing
FAQ

Common questions

What is Gastro Compass?

Gastro Compass is the umbrella project behind GastroLens. It brings together the research framing, product context, live app access, and ongoing updates in one place.

Is GastroLens available now?

Yes. GastroLens is now live in a first version through the GastroCompass site as an interactive research-mode assessment tool.

What does GastroLens do?

GastroLens is a symptom-first GI risk flagging tool that helps organize persistent warning signs, risk context, and follow-up-ready summaries for under-50 colorectal cancer concern.

Are the dashboard tabs live product features?

No. The Patient View, Professional View, AI Review, and Exports tabs still represent broader product directions beyond the current live first version.

Is GastroLens a diagnosis tool?

No. GastroLens is framed as a non-diagnostic escalation support tool. It is not clinically validated and is not meant to replace professional medical care.

Why focus on early-onset colorectal cancer first?

The research direction is focused on the documented failure mode where symptoms are present in under-50 patients but repeatedly dismissed, making symptom-first risk flagging more clinically meaningful than a broad GI classifier.

Is the imaging component live today?

No. Imaging remains a roadmap feature and will only make sense once it can be trained and validated on clinically meaningful data. The symptom-side is the first build.

How can I follow GastroLens updates?

Join the waitlist to get updates about new features, research progress, product improvements, and future rollout milestones.

GastroLens updates

Get GastroLens Updates

Get notified about product improvements, research milestones, and future rollout updates as GastroLens continues to evolve.

Contact

Get in touch

General contact

Email the team

Questions about the project, early access, research interest, or future clinical partnerships can be sent directly by email.

tanush.nimmalapudi@gastrocompass.org
Best for

What to reach out about

Early access Research Clinical partnerships School projects Product feedback

For now, the fastest way to connect is by email while the full waitlist and contact workflow is being built.